BVF group reports 19.7% MoonLake Immunotherapeutics (MLTX) stake
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A group known as BVF has reported a stake in MoonLake Immunotherapeutics, which is referred to by the symbol MLTX. The reported stake is 19.7% of the company. This indicates that BVF has a significant ownership interest in MoonLake Immunotherapeutics.